| Application of Patient Blood Management in the Oncology Patient Affected by Breast Cancer (NCT06883201) | Regina Elena Cancer Institute | 2023-01-31 |
| Patient-centered Breast Cancer Teleprehabilitation (NCT05782504) | Universitair Ziekenhuis Brussel | 2023-01-30 |
| Study of Aerobic Training for People Receiving Treatment for Breast Cancer (NCT05716893) | Memorial Sloan Kettering Cancer Center | 2023-01-30 |
| Evaluation of TaiHao Breast Ultrasound Diagnosis Software RN-CES Descartes (NCT05792475) | TaiHao Medical Inc. | 2023-01-30 |
| Clinical Study of the Efficacy and Safety of BCD-178 and Perjeta® as Neoadjuvant Therapy of HER2-Positive Breast Cancer (NCT05802225) | Biocad | 2023-01-30 |
| Endometrial Changes in Breast Cancer Women. (NCT05717634) | Regina Elena Cancer Institute | 2023-01-26 |
| Endoscopic Assisted Latissimus Dorsi Musculocutaneous Flap for Breast Reconstruction (NCT07691294) | Kasr El Aini Hospital | 2023-01-25 |
| Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer (NCT05563220) | Stemline Therapeutics, Inc. | 2023-01-24 |
| Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System (NCT05291507) | University of Utah | 2023-01-23 |
| Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia (NCT05703178) | Northwestern University | 2023-01-19 |
| Effectiveness Validation of CELBREA® in Symptomatic Women or With Diagnostic Doubt of Breast Pathology (DETECT-BH) (NCT05857111) | Jose Ignacio Sánchez | 2023-01-18 |
| Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care (NCT05483283) | University of Illinois at Chicago | 2023-01-18 |
| Brass Mesh Bolus in Rotational Post-Mastectomy Radiation Therapy (NCT05483712) | Nova Scotia Cancer Centre | 2023-01-18 |
| Effect of Planned Education on Health Beliefs and Fatalism in Women at High Risk of Breast Cancer (NCT06690320) | Ege University | 2023-01-17 |
| Biomarkers of Efficacy and Tolerability of Sacituzumab-Govitecan in the Treatment of Patients With Triple-negative Breast Cancer in the Metastatic Phase: Prospective Multicenter Real-world Study (NCT06240195) | Regina Elena Cancer Institute | 2023-01-17 |
| A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors (NCT05576077) | Turnstone Biologics, Corp. | 2023-01-17 |
| Multimodal Project (NCT05656716) | Universidad de Granada | 2023-01-15 |
| Real-Life Pilot Feasibility Study (LC_RLP) (NCT05797727) | Aristotle University Of Thessaloniki | 2023-01-15 |
| Understanding CARdiac Events in Breast Cancer (NCT05921279) | National University of Ireland, Galway, Ireland | 2023-01-14 |
| Feasibility of Implementing Acupuncture Into Federally Qualified Health Center Among Breast Cancer Survivors (NCT05615753) | University of Illinois at Chicago | 2023-01-12 |
| Effects of Exercise Oncology Intervention in Fitness Capacity and Body Composition in Breast Cancer Survivals (NCT05882578) | Tigers Running Club | 2023-01-12 |
| Effects of 'Pinkwashed' Alcohol Ads in an Online RCT (NCT05700019) | University of North Carolina, Chapel Hill | 2023-01-11 |
| Algology in Oncology Osteopathic Support (ALGOS) (NCT05726929) | Institut Toulousain d'Ostéopathie | 2023-01-11 |
| A Prospective Phase II Study for Adjuvant Hypofractionated Intensity-modulated Proton Radiotherapy for Post Operative Breast Cancer With Implantation Reconstruction (NCT05692674) | Shanghai Proton and Heavy Ion Center | 2023-01-10 |
| Young Breast Cancer Survivors Study (NCT05981716) | University of South Carolina | 2023-01-10 |
| Phase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast Cancer (NCT05384119) | Tvardi Therapeutics, Incorporated | 2023-01-09 |
| PBI for Breast in Situ Carcinoma of Intermediate Low Risk As Local Adjuvant Treatment (NCT05663294) | Istituto Clinico Humanitas | 2023-01-09 |
| Evaluation of the Functional/Emotional Life Characteristics of Ongoing EAT in BC Patients With Reduced BMD (NCT05779566) | Fundación para la Investigación del Hospital Clínico de Valencia | 2023-01-09 |
| A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection (NCT05300464) | Umbria Bioengineering Technologies | 2023-01-07 |
| Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment (NCT05926024) | UNC Lineberger Comprehensive Cancer Center | 2023-01-06 |
| Feasibility of Exosome Analysis in Cerebrospinal Fluid During the Diagnostic Workup of Metastatic Meningitis (NCT05286684) | Centre Oscar Lambret | 2023-01-04 |
| HER2 Expression of CTC to Predict Response in HER2-low Advanced Breast Cancer Patients Treated With ADC (NCT05834699) | Beijing 302 Hospital | 2023-01-01 |
| Prophylactic Irradiation to the Contralateral Breast for BCAs Patients (NCT04960839) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2023-01-01 |
| Together After Cancer (NCT05645471) | University of South Florida | 2023-01-01 |
| MEthods for LOcalization of Different Types of Breast Lesions (NCT05559411) | European Breast Cancer Research Association of Surgical Trialists | 2023-01-01 |
| Real-World Study on CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent Treatment in HR+/HER2- MBC. (NCT06033287) | Hunan Cancer Hospital | 2023-01-01 |
| Frequency of Occult Breast Cancer After Prophylactic Mastectomy Among High-Penetrance Breast Cancer Gene Positives (NCT05771454) | Aga Khan University Hospital, Pakistan | 2023-01-01 |
| A Retrospective Analysis of Magnetic Resonance Imaging Data for Breast Cancer Screening in the Open Consortium for Decentralized Medical Artificial Intelligence (NCT05698056) | Technische Universität Dresden | 2023-01-01 |
| Metronomic Chemotherapy in a Real-world Population of Advanced Breast Cancer Patients (NCT06373744) | Sun Yat-sen University | 2023-01-01 |
| Timing of Surgery and the Evolution of Postoperative Outcomes in Breast Cancer Patients Undergoing Surgical Intervention Following Recovery From SARS-CoV-2 Infection (NCT06319209) | Fujian Medical University Union Hospital | 2023-01-01 |
| The Effect of Body Mass Index and Total Cholesterol Levels on Histopathological Grading in Breast Cancer Patients (NCT06786598) | Latakia University | 2023-01-01 |
| Fenofibrate Role in Breast Cancer Patients (NCT05813145) | Damanhour University | 2023-01-01 |
| Realistic Evaluation of a Job Retention Program After Breast Cancer (NCT05919498) | Hospices Civils de Lyon | 2023-01-01 |
| Safety and Efficacy Real-world Data of Trastuzumab Deruxtecan and Sacituzumab Govitecan (NCT06504719) | Hellenic Cooperative Oncology Group | 2023-01-01 |
| HER2 Expression of CTC to Predict Response in HER2-positive Advanced Breast Cancer Patients Treated With ADC (NCT05834686) | Beijing 302 Hospital | 2023-01-01 |
| Prediction of Long-term Arm Morbidity Following Breast Cancer Surgeries and Treatments (NCT05950685) | Ifat Klein | 2023-01-01 |
| Sentinel Lymph Node Localisation With an Ultra-low Dose of Magtrace in Breast Cancer Patients (NCT06169072) | Vastra Gotaland Region | 2023-01-01 |
| Dexmedetomedine and Ketamine in Erector Spinae Block for Postoperative Analgesia Following Mastectomy. (NCT05727098) | National Cancer Institute, Egypt | 2023-01-01 |
| Prevalence and Risk Factors for Pain and Related Adverse Reactions Among Breast Cancer Survivors on Aromatase Inhibitors (NCT05628077) | Peking University People's Hospital | 2022-12-30 |
| Pulsed Electromagnetic Fields (PEMFs) - A Highly Selective Breast CAncer Treatment pLatform (PASCAL) (NCT06332508) | National University Hospital, Singapore | 2022-12-30 |
| SNF Platform Study of HR+/ HER2-advanced Breast Cancer (NCT05594095) | Fudan University | 2022-12-30 |
| Study of AC699 in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast Cancer (NCT05654532) | Accutar Biotechnology Inc | 2022-12-29 |
| Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study (NCT05645536) | Tolmar Inc. | 2022-12-28 |
| Opioid-free Anaesthesia in Breast Cancer Surgery (NCT06404983) | University of Ioannina | 2022-12-28 |
| A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors (NCT05538572) | Prelude Therapeutics | 2022-12-27 |
| Evaluate Impact of Exercise Program on Fatigue in Breast Cancer During Chemotherapy (NCT05704842) | Virtua Health, Inc. | 2022-12-22 |
| Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors (NCT05283330) | Orano Med Theranostics, SAS | 2022-12-22 |
| A Real-world Study of Indian Patients With Advanced Breast Cancer Treated With Ribociclib (NCT07363434) | Novartis Pharmaceuticals | 2022-12-21 |
| EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients (NCT07478016) | Thomas Jefferson University | 2022-12-21 |
| Investigation of Urinary Biomarkers for the Detection of Breast Cancer (NCT05453591) | Novosanis NV | 2022-12-21 |
| Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast Cancer (NCT05475678) | Zhenzhen Liu | 2022-12-20 |
| Evaluation of Novel Cone-Beam CT for Guidance and Adaptation of Precision Radiotherapy (NCT05176860) | Varian, a Siemens Healthineers Company | 2022-12-20 |
| Pyrotinib Combined With Trastuzumab, Dalpiciclib, Letrozole Versus TCbHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HR +/HER2 + Breast Cancer (NCT05638594) | Shengjing Hospital | 2022-12-20 |
| A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer (NCT05653752) | MediLink Therapeutics (Suzhou) Co., Ltd. | 2022-12-20 |
| Water and Land-based Aerobic Training in Breast Cancer Survivors (NCT05520515) | Federal University of Pelotas | 2022-12-19 |
| Study of SHR6390 in Renal Insufficiency and Healthy Subjects (NCT05515289) | Jiangsu HengRui Medicine Co., Ltd. | 2022-12-18 |
| Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects (NCT05232916) | Greenwich LifeSciences, Inc. | 2022-12-16 |
| Resistance vs. Aerobic Training on Breast Cancer Patients Undergoing Neoadjuvant Treatment (NCT05297773) | Fundacao Champalimaud | 2022-12-16 |
| Weight Loss and Breast Cancer (NCT05654571) | Fatih Sultan Mehmet Training and Research Hospital | 2022-12-15 |
| Chemotherapy Induced Cognitive Impairment (NCT05740787) | University of Aberdeen | 2022-12-15 |
| Phase I Study of ZN-c3 and Bevacizumab ± Pembrolizumab in Metastatic CCNE1 Amplified and TP53 Mutant Solid Tumors (NCT05431582) | M.D. Anderson Cancer Center | 2022-12-14 |
| Ribociclib Real-world Treatment Patterns and Clinical Outcomes Among Women With HR+/HER2- Advanced or Metastatic Breast Cancer in France (NCT05697146) | Novartis Pharmaceuticals | 2022-12-13 |
| Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1) (NCT05501886) | Celcuity Inc | 2022-12-08 |
| Standard Surveillance vs. Intensive Surveillance in Early Breast Cancer (NCT05658172) | Prof. Wolfgang Janni | 2022-12-07 |
| Opioid Free Versus Opioid Based Anaesthesia for Free Flap Reconstruction Surgery of the Breast: A Phase III Multicentric Randomized Controlled Study. (NCT05439005) | Institut Curie | 2022-12-07 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903 (NCT06846099) | Risen (Suzhou) Pharma Tech Co., Ltd. | 2022-12-07 |
| Kadcyla And Neratinib for Interception of HER2+ Breast Cancer With Molecular Residual Disease (NCT05388149) | University Health Network, Toronto | 2022-12-06 |
| Performance Assessment of the Fluorescence Technique Alone in the Search for the Sentinel Node in Breast Surgery (NCT05588414) | Centre Hospitalier Annecy Genevois | 2022-12-05 |
| Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC (NCT05645380) | University of Kansas Medical Center | 2022-12-05 |
| SexoMBC2 Non Interventional Study (NCT05577156) | Institut de Cancérologie de Lorraine | 2022-12-05 |
| The C-MERIT Screening Cohort: Contrast-enhanced Mammography for Breast Cancer Screening and Risk Assessment in Women With Dense Breasts (NCT05667532) | M.D. Anderson Cancer Center | 2022-12-05 |
| EvoLution of Neoadjuvant TreatMent in 'Triple-negative' or 'HER-2-positive' Breast Cancer Diagnosed in the EaRly Phase (NCT06894173) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2022-12-03 |
| Study of Elacestrant in Combination With Onapristone in Patients With Advanced or Metastatic Breast Cancer (NCT05618613) | Context Therapeutics Inc. | 2022-12-02 |
| Prehabilitation and Rehabilitation in Breast Cancer Surgery Patients - a Pilot Study (NCT06076616) | Franciscus Gasthuis | 2022-12-01 |
| Prevention of Radiodermatitis in Breast and Head and Neck Cancer Patients in Cyprus (NCT05588973) | Angelos Kassianos | 2022-12-01 |
| Effect of Bra Use During Radiotherapy for Breast Cancer Radiotherapy (NCT06178861) | Yonsei University | 2022-12-01 |
| A Phase II Trial of Camrelizumab in Combination With Apatinib for Neoadjuvant Treatment of Early-stage TNBC With a High Proportion of TILs (NCT05556200) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2022-12-01 |
| Negative ER Expression Assessed by 18F-FES PET/CT in the MBC With ER-positive Primary Tumor (NCT05797987) | Fudan University | 2022-12-01 |
| Circulating Tumour Cells Characterization in Breast Cancer Patients (NCT06048835) | Istituti Clinici Scientifici Maugeri SpA | 2022-12-01 |
| A Phase 1 Study to Evaluate Paclitaxel Conjugated CXC Receptor 4 Antagonist (MB1707) in Patients With Advanced Cancer (NCT05465590) | Mainline Biosciences, Inc. | 2022-12-01 |
| Study of Acupuncture in the Treatment of Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer. (NCT05613504) | Nanjing University of Traditional Chinese Medicine | 2022-12-01 |
| Neoadjuvant Treatment of Locally-advanced Breast Cancer Patients With Ribociclib and Letrozole (NCT05163106) | University Hospital, Akershus | 2022-12-01 |
| Prospective Cohort for Tumor Bed Boost Radiotherapy in HER2 Positive Breast Cancer (NCT05893966) | Samsung Medical Center | 2022-11-29 |
| Neoadjuvant Study With Pyrotinib and Trastuzumab and Abraxane in Patients With HER2-enriched Breast Cancer (NCT05659056) | The First Affiliated Hospital with Nanjing Medical University | 2022-11-29 |
| Oral AMXT 1501 Dicaprate in Combination With IV DFMO (NCT05500508) | Aminex Therapeutics, Inc. | 2022-11-29 |
| A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03) (NCT05629585) | AstraZeneca | 2022-11-28 |
| Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC) (NCT05629065) | Dana-Farber Cancer Institute | 2022-11-28 |
| African Cancer Genome: GMD (NCT05754658) | Fox Chase Cancer Center | 2022-11-28 |
| Functional Evaluation After Breast Reconstruction With a Minimally Invasive Latissimus Dorsi Flap Following Radical Surgery for Breast Cancer. (NCT05278741) | Centre Georges Francois Leclerc | 2022-11-25 |
| NeoadjuVAnt muLti-agENT Chemotherapy or Patritumab Deruxtecan With or Without endocrINE Therapy for High-risk HR+/HER2- Breast Cancer - VALENTINE Trial (NCT05569811) | SOLTI Breast Cancer Research Group | 2022-11-25 |